Pancreatic cancer
12.8×better odds
There is no routine screening test for ovarian cancer, and 54% of cases have already spread to other organs by the time they are found. Caught early, survival is nearly three times better.
| Stage at diagnosis | 5-year survival | Share of cases |
|---|---|---|
| Caught early : Still only where it started. This is what screening looks for. | 91.9% | 22.0% |
| Spread nearby : Reached lymph nodes or tissue next to where it started. | 70.1% | 18.0% |
| Caught late : Reached organs elsewhere in the body. Doctors call this metastatic. | 31.5% | 54.0% |
| Stage unknown : The record did not say how far it had spread. | 38.5% | 6.0% |
| All cases : Everyone diagnosed, early and late together. | 52.0% | n/a |
Source: NCI SEER Cancer Stat Facts, cases diagnosed 2016-2022.
Figures are 5-year relative survival by SEER stage at diagnosis from the NCI Surveillance, Epidemiology, and End Results (SEER) program. They describe outcomes by the stage at which a cancer was found; they are not outcomes attributable to whole-body MRI screening, which has not been shown in randomized trials to reduce cancer mortality. What these numbers do and do not show.
2.9×
Better odds of being alive five years later when ovarian cancer is caught before it spreads, compared with after it has reached other organs.
54.0% of ovarian cancer cases have already spread to other organs by the time anyone looks.
12.8×better odds
10.4×better odds
4.6×better odds
5-year relative survival, 2016-2022. NCI SEER Cancer Stat Facts
One scan from $999. 30 to 60 minutes. No radiation, no contrast dye, no referral needed.